These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8100929

  • 1. Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine.
    Ramsay ME, Rao M, Begg NT, Redhead K, Attwell AM.
    Lancet; 1993 Jul 24; 342(8865):203-5. PubMed ID: 8100929
    [Abstract] [Full Text] [Related]

  • 2. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
    Ramsay ME, Corbel MJ, Redhead K, Ashworth LA, Begg NT.
    BMJ; 1991 Jun 22; 302(6791):1489-91. PubMed ID: 1855015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age.
    Booy R, Aitken SJ, Taylor S, Tudor-Williams G, Macfarlane JA, Moxon ER, Ashworth LA, Mayon-White RT, Griffiths H, Chapel HM.
    Lancet; 1992 Feb 29; 339(8792):507-10. PubMed ID: 1346876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L.
    Pediatrics; 1999 Jan 29; 103(1):25-30. PubMed ID: 9917435
    [Abstract] [Full Text] [Related]

  • 7. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A, Stage III Working Group.
    Pediatrics; 2001 Nov 29; 108(5):E81. PubMed ID: 11694665
    [Abstract] [Full Text] [Related]

  • 8. [Antibody levels for diphtheria, tetanus and pertussis in young adult females immunized with whole cell pertussis-diphtheria-tetanus toxoid vaccine in infancy].
    Meno Y, Okada K, Yamaguchi Y, Morokuma K, Okuma K, Ueda K.
    Kansenshogaku Zasshi; 2000 Feb 29; 74(2):150-4. PubMed ID: 10741006
    [Abstract] [Full Text] [Related]

  • 9. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.
    Robinson MJ, Heal C, Gardener E, Powell P, Sims DG.
    Pediatrics; 2004 Apr 29; 113(4):733-7. PubMed ID: 15060220
    [Abstract] [Full Text] [Related]

  • 10. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
    Pasetti M, Eriksson P, Ferrero F, Manghi M.
    Infection; 1997 Apr 29; 25(6):339-45. PubMed ID: 9427051
    [Abstract] [Full Text] [Related]

  • 11. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B, Knutsson N, Taranger J, Mark A, Bergfors E, Sundh V, Lagergård T.
    Eur J Pediatr; 2006 Jan 29; 165(1):14-8. PubMed ID: 16249929
    [Abstract] [Full Text] [Related]

  • 12. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S, Jeddi-Tehrani M, Akhondi MM, Zeraati H, Pourheidari F, Ostadkarampour M, Tavangar B, Shokri F.
    Iran J Allergy Asthma Immunol; 2009 Jun 29; 8(2):85-93. PubMed ID: 19671937
    [Abstract] [Full Text] [Related]

  • 13. Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.
    Vandermeulen C, Theeten H, Rathi N, Kuriyakose S, Han HH, Sokal E, Hoppenbrouwers K, Van Damme P.
    Vaccine; 2015 Jun 12; 33(26):3026-34. PubMed ID: 25613716
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD.
    Pediatrics; 2000 Jan 12; 105(1):e11. PubMed ID: 10617748
    [Abstract] [Full Text] [Related]

  • 15. Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up.
    Swartz TA, Saliou P, Catznelson E, Blondeau C, Gil I, Peled T, Havkin O, Fletcher M.
    Eur J Epidemiol; 2003 Jan 12; 18(8):827-33. PubMed ID: 12974560
    [Abstract] [Full Text] [Related]

  • 16. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.
    Pediatrics; 1997 Nov 12; 100(5):772-88. PubMed ID: 9346976
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
    Kovac M, Kostanyan L, Mesaros N, Kuriyakose S, Varman M.
    Hum Vaccin Immunother; 2018 Nov 12; 14(8):1977-1986. PubMed ID: 29630439
    [Abstract] [Full Text] [Related]

  • 18. Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study.
    Maertens K, Caboré RN, Huygen K, Hens N, Van Damme P, Leuridan E.
    Vaccine; 2016 Jan 02; 34(1):142-50. PubMed ID: 26592142
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to diphtheria, tetanus and pertussis in infants before and after immunization with DTP (Triple Antigen) vaccine.
    Stewart TA, Nolan TM, Hogg G, McEwen J.
    J Paediatr Child Health; 1996 Oct 02; 32(5):378-81. PubMed ID: 8933394
    [Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.
    Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R.
    Scand J Infect Dis; 1995 Oct 02; 27(3):279-87. PubMed ID: 8539554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.